Abstract
Non-pharmaceutical interventions during the COVID-19 pandemic significantly disrupted social mixing patterns, creating a need for updated mathematical models to guide an effective response. Accurately capturing evolving, age-specific social contacts has proven challenging. This study evaluates the effectiveness of mobility-driven synthetic contact matrices against survey-based empirical matrices in capturing the dynamics of COVID-19 observed in France from March 2020 to May 2022. Both matrices showed a gradual increase in average contacts following the first lockdown, with the closest agreement during school closures. However, when schools were open, empirical matrices recorded 3.4 times more contacts for individuals under 19 than synthetic matrices. The model parameterized with mobility-driven contact matrices provided the best fit to hospital admission data and captured hospitalization patterns for adolescents, adults, and seniors, whereas deviations remained for children across both models. Neither matrix allowed models to accurately reproduce serological trends in children in 2021, highlighting the challenges both approaches face in capturing disease-relevant contacts in children. These findings demonstrate the value of synthetic matrices as flexible, cost-effective tools for epidemic modeling, operationally ready in real-time. Routine collection of age-stratified mobility data is essential to improve pandemic response.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was partially funded by: ANR grant DATAREDUX (ANR-19-CE46-0008-03); EU Horizon 2020 grant MOOD (H2020-874850); Horizon Europe grants VERDI (101045989) and ESCAPE (101095619).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study used only human data that were collected and made available before the initiation of the study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
DATA AVAILABILITY STATEMENT
Code of the transmission model is publicly available at https://github.com/EPIcx-lab/COVID-19/tree/master/mobility_driven_synthetic_contact_matrices, along with the mobility-driven synthetic contact matrices. SocialCov survey data are available from the co-authors P.B. and L.O. upon request. All other data used in the analyses are available online at the cited references.
